StockData
Novo Nordisk A S logo

Novo Nordisk A S

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)

Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –

Novo Nordisk A S Parent Company (Novo Nordisk A/S) by Year

Parent Company (Novo Nordisk A/S) — Standalone operating profit (DKKm)

Novo Nordisk A S Parent Company (Novo Nordisk A/S): 116,203.00 DKKm in FY2025, down 5.0% from a year earlier.

Latest, FY2025
116,203.00
Period ended Dec 31, 2025
Change on a year earlier
-5.0%
122,352.00 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below

Where the FY2025 figure comes from

“|| Operating profit | 116,203 | 122,352”

Source: Form 20-F (filed 2026-02-04) ↗

Reported in Novo Nordisk Annual Report — Financial Statements of the Parent Company (Income Statement).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedParent Company (Novo Nordisk A/S) — Standalone operating profit (DKKm)Year on yearSource
FY2025Dec 31, 2025116,203.00-5.0%Form 20-F (filed 2026-02-04) ↗
FY2024Dec 31, 2024122,352.00+39.1%Form 20-F (filed 2026-02-04) ↗
FY2023Dec 31, 202387,936.00+63.5%Form 20-F (filed 2025-02-05) ↗
FY2022Dec 31, 202253,788.00+35.5%Form 20-F (filed 2024-01-31) ↗
FY2021Dec 31, 202139,702.00+1.4%Form 20-F (filed 2023-02-01) ↗
FY2020Dec 31, 202039,144.00-0.6%Form 20-F (filed 2022-02-02) ↗
FY2019Dec 31, 201939,390.00–Form 6-K (filed 2021-02-03) ↗

Breakdown

What makes up parent Company (Novo Nordisk A/S)

Cite this data

StockData. (2026). Novo Nordisk A S Parent Company (Novo Nordisk A/S), annual FY2019–FY2025 [Data set]. Compiled from Novo Nordisk A S SEC filings and investor materials. https://stockdatahq.com/stocks/nvo/kpis/parent-ebit

See every metric in the Novo Nordisk A S KPI table. Data updated Nov 3, 2026.

See a number that looks wrong?